Ueda Kousuke 植田浩介

… Alternative Names

Ueda Kosuke 植田浩介

Less

Researcher Number	60569440
Other IDs
Affiliation (Current)	2025: 久留米大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2021 – 2024: 久留米大学, 医学部, 講師 2018 – 2020: 久留米大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 56030:Urology-related Except Principal Investigator Basic Section 57060:Surgical dentistry-related / Basic Section 56030:Urology-related
Keywords	Principal Investigator 腸内細菌 / 腎細胞癌 / 免疫療法 / ウイルス / 真菌 / 腸内微生物叢 / 抗PD-1抗体 / 免疫チェックポイント阻害薬 / 漢方薬 / 腸内細菌叢 / 免疫チェックポイント阻害剤 … More Except Principal Investigator … More 免疫チェックポイント分子 / 口腔扁平上皮癌 / クロストーク解析 / がん幹細胞 / 個別化治療 / 尿路がん / がんワクチン / 複合療法 / 複合免疫療法 / 尿路上皮がん / がんペプチドワクチン / がん免疫療法 Less

口腔癌の癌幹細胞と周囲微小環境とのクロストーク機構解析による新規治療戦略の確立
- Principal Investigator
  
  轟圭太
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 57060:Surgical dentistry-related
- Research Institution
  Kurume University
Association between efficacy of Immuno-Oncology combination therapy for renal cell carcinoma and gut microbiota including fungi and virusesPrincipal Investigator
- Principal Investigator
  
  植田浩介
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kurume University
Association between anti-tumor effect of Kampo combined with anti-PD-1 antibody and interstinal microbiotaPrincipal Investigator
- Principal Investigator
  
  Ueda Kosuke
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kurume University
Next generation personalized peptide vaccination for advanced urothelial carcinoma patients
- Principal Investigator
  
  Suekane Shigetaka
- Project Period (FY)
  2018 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kurume University

All 2024 2023 2022 2021 2020 2019

All Journal Article Presentation

[Journal Article] Three‐dimensional ultrastructural and anatomical analysis of prostatic neuroendocrine cells in mice2024
- Author(s)
  Uemura Kei‐Ichiro、Togo Akinobu、Hiroshige Tasuku、Ohta Keisuke、Ueda Kosuke、Nishihara Kiyoaki、Nakiri Makoto、Hirashima Shingo、Igawa Tsukasa、Nakamura Kei‐Ichiro
- Journal Title
  
  The Prostate
  
  Volume: 84 Issue: 9 Pages: 866-876
- DOI
  10.1002/pros.24705
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K06329, KAKENHI-PROJECT-23K08749, KAKENHI-PROJECT-20K06730, KAKENHI-PROJECT-20H03290
[Journal Article] Soluble Immune Checkpoint Molecules as Predictors of Efficacy in Immuno-Oncology Combination Therapy in Advanced Renal Cell Carcinoma2024
- Author(s)
  Ueda Kosuke、Uemura Keiichiro、Ito Naoki、Sakai Yuya、Ohnishi Satoshi、Suekane Hiroki、Kurose Hirofumi、Hiroshige Tasuku、Chikui Katsuaki、Nishihara Kiyoaki、Nakiri Makoto、Suekane Shigetaka、Ogasawara Sachiko、Yano Hirohisa、Igawa Tsukasa
- Journal Title
  
  Current Oncology
  
  Volume: 31 Issue: 4 Pages: 1701-1712
- DOI
  10.3390/curroncol31040129
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K08749
[Journal Article] Prognostic Value of Absolute Lymphocyte Count in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab Plus Ipilimumab2023
- Author(s)
  Ueda Kosuke、Ogasawara Naoyuki、Ito Naoki、Ohnishi Satoshi、Suekane Hiroki、Kurose Hirofumi、Hiroshige Tasuku、Chikui Katsuaki、Uemura Keiichiro、Nishihara Kiyoaki、Nakiri Makoto、Suekane Shigetaka、Igawa Tsukasa
- Journal Title
  
  Journal of Clinical Medicine
  
  Volume: 12 Issue: 6 Pages: 2417-2417
- DOI
  10.3390/jcm12062417
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K18128, KAKENHI-PROJECT-23K08749
[Journal Article] Impact of Gleason score of the tumor at the positive surgical margin as a prognostic factor2022
- Author(s)
  Kurose Hirofumi、Ueda Kosuke、Ogasawara Naoyuki、Chikui Katsuaki、Nakiri Makoto、Nishihara Kiyoaki、Matsuo Mitsunori、Suekane Shigetaka、Kusano Hironori、Akiba Jun、Yano Hirohisa、Igawa Tsukasa
- Journal Title
  
  Molecular and Clinical Oncology
  
  Volume: 16 Issue: 4 Pages: 1-7
- DOI
  10.3892/mco.2022.2515
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09182
[Journal Article] Immune-related adverse events are clinical biomarkers to predict favorable outcomes in advanced renal cell carcinoma treated with nivolumab plus ipilimumab2022
- Author(s)
  Ueda Kosuke、Suekane Shigetaka、Kurose Hirofumi、Ito Naoki、Ogasawara Naoyuki、Hiroshige Tasuku、Chikui Katsuaki、Ejima Kazuhisa、Uemura Keiichiro、Nakiri Makoto、Nishihara Kiyoaki、Igawa Tsukasa
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 1 Issue: 5 Pages: 1-8
- DOI
  10.1093/jjco/hyac009
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09182, KAKENHI-PROJECT-20K18128
[Journal Article] Improved Survival of Real-world Japanese Patients With Advanced Renal Cell Carcinoma Treated With Immuno-oncology Combination Therapy2022
- Author(s)
  UEDA KOSUKE、SUEKANE SHIGETAKA、KUROSE HIROFUMI、ITO NAOKI、OGASAWARA NAOYUKI、HIROSHIGE TASUKU、CHIKUI KATSUAKI、EJIMA KAZUHISA、UEMURA KEIICHIRO、NAKIRI MAKOTO、NISHIHARA KIYOAKI、MATSUO MITSUNORI、IGAWA TSUKASA
- Journal Title
  
  Anticancer Research
  
  Volume: 42 Issue: 9 Pages: 4573-4580
- DOI
  10.21873/anticanres.15960
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K18128
[Journal Article] FXYD3 Expression Predicts Poor Prognosis in Renal Cell Carcinoma with Immunosuppressive Tumor Microenvironment2022
- Author(s)
  Yonekura Satoru、Ueda Kosuke
- Journal Title
  
  Cancers
  
  Volume: 14 Issue: 15 Pages: 3596-3596
- DOI
  10.3390/cancers14153596
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K18128
[Journal Article] Survival outcomes of non?definitive therapy for muscle?invasive bladder cancer2022
- Author(s)
  Nishihara Kiyoaki、Ueda Kosuke、Kurose Hirofumi、Ogasawara Naoyuki、Hiroshige Tasuku、Chikui Katsuaki、Ejima Kazuhisa、Uemura Keiichiro、Nakiri Makoto、Suekane Shigetaka、Igawa Tsukasa
- Journal Title
  
  Oncology Letters
  
  Volume: 23 Issue: 4 Pages: 1-8
- DOI
  10.3892/ol.2022.13246
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09182
[Journal Article] Absolute lymphocyte count is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with nivolumab2021
- Author(s)
  Ueda Kosuke、Suekane Shigetaka、Kurose Hirofumi、Ogasawara Naoyuki、Hiroshige Tasuku、Chikui Katsuaki、Uemura Keiichiro、Nakiri Makoto、Nishihara Kiyoaki、Matsuo Mitsunori、Igawa Tsukasa
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 52 Issue: 2 Pages: 179-186
- DOI
  10.1093/jjco/hyab157
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09182, KAKENHI-PROJECT-20K18128
[Journal Article] External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort2021
- Author(s)
  Tamura Keita、Osawa Takahiro、Takeuchi Ario、Minami Keita、Nakai Yasutomo、Ueda Kosuke、Ozawa Michinobu、Uemura Motohide、Sugimoto Mikio、Ohba Kojiro、Suzuki Toshihiro、Anai Satoshi、Shindo Tetsuya、Kusakabe Naohisa、Komiyama Motokiyo、Tanaka Ken、Yokomizo Akira
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 51 Issue: 5 Pages: 810-818
- DOI
  10.1093/jjco/hyaa264
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K18128
[Journal Article] Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinoma2020
- Author(s)
  Osawa Takahiro,Kojima Takahiro,Hara Tomohiko,Sugimoto Mikio,Eto Masatoshi,Takeuchi Ario,Minami Keita,Nakai Yasutomo,Ueda Kosuke,Ozawa Michinobu,Uemura Motohide,Miyauchi Yasuyuki,Ohba Kojiro,Suzuki Toshiro,Anai Satoshi,Shindo Tetsuya,Kusakabe Naohisa,Tamura Keita,Komiyama Motokiyo,Goto Takayuki,Yokomizo Akira
- Journal Title
  
  Cancer Science
  
  Volume: 111 Issue: 7 Pages: 2460-2471
- DOI
  10.1111/cas.14449
- NAID
  120007159551
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K18128
[Journal Article] Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients2020
- Author(s)
  Suekane Shigetaka、Yutani Shigeru、Yamada Akira、Sasada Tetsuro、Matsueda Satoko、Takamori Shinzo、Toh Uhi、Kawano Kouichiro、Yoshiyama Koichi、Sakamoto Shinjiro、Sugawara Shunichi、Komatsu Nobukazu、Yamada Teppei、Naito Masayasu、Terasaki Mizuhiko、Mine Takashi、Itoh Kyogo、Shichijo Shigeki、Noguchi Masanori
- Journal Title
  
  International Journal of Oncology
  
  Volume: 56 Pages: 1479-1489
- DOI
  10.3892/ijo.2020.5019
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09182, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-18K19490
[Journal Article] A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data2020
- Author(s)
  Hinata Nobuyuki、Yonese Junji、Masui Satoru、Nakai Yasutomo、Shirotake Suguru、Tatsugami Katsunori、Inamoto Teruo、Nozawa Masahiro、Ueda Kosuke、Etsunaga Toru、Osawa Takahiro、Uemura Motohide、Kimura Go、Numakura Kazuyuki、Yamana Kazutoshi、Miyake Hideaki、Fukasawa Satoshi、Ochi Kenya、Kaneko Hirokazu、Uemura Hirotsugu
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 25 Issue: 8 Pages: 1533-1542
- DOI
  10.1007/s10147-020-01692-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K18128
[Journal Article] Efficacy and safety of second-line axitinib in octogenarians with metastatic renal cell carcinoma2020
- Author(s)
  Nakai Yasutomo,Takeuchi Ario,Osawa Takahiro,Kojima Takahiro,Hara Tomohiko,Sugimoto Mikio,Eto Masatoshi,Minami Keita,Ueda Kosuke,Ozawa Michinobu,Uemura Motohide,Miyauchi Yasuyuki,Ohba Kojiro,Kashiwagi Akira,Murakami Masaya,Sazuka Tomokazu,Yasumoto Hiroaki,Morizane Shuichi,Kawasaki Yoshihide,Morooka Daichi,Shimazui Toru
- Journal Title
  
  Journal of Geriatric Oncology
  
  Volume: 30 Issue: 5 Pages: 30534-30538
- DOI
  10.1016/j.jgo.2020.12.012
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K18128
[Journal Article] The Impact of Antibiotics on Prognosis of Metastatic Renal Cell Carcinoma in Japanese Patients Treated With Immune Checkpoint Inhibitors2019
- Author(s)
  UEDA KOSUKE、YONEKURA SATORU、OGASAWARA NAOYUKI、MATSUNAGA YOSHIHIRO、HOSHINO RYUJI、KUROSE HIROFUMI、CHIKUI KATSUAKI、UEMURA KEIICHIRO、NAKIRI MAKOTO、NISHIHARA KIYOAKI、MATSUO MITSUNORI、SUEKANE SHIGETAKA、IGAWA TSUKASA
- Journal Title
  
  Anticancer Research
  
  Volume: 39 Issue: 11 Pages: 6265-6271
- DOI
  10.21873/anticanres.13836
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K09182
[Presentation] Efficacy and safety of nivolumab plus ipilimumab in elderly patients with advanced renal cell carcinoma2024
- Author(s)
  Kosuke Ueda, Naoki Ito, Yuya Sakai, Satoshi Ohnishi, Hirofumi Kurose, Tasuku Hiroshige, Katsuaki Chikui, Keiichiro Uemura, Kiyoaki Nishihara, Makoto Nakiri, Shigetaka Suekane, Tsukasa Igawa
- Organizer
  第111回日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-23K08749
[Presentation] Efficacy and safety of avelumab plus axitinib for advanced renal cell carcinoma in patients over 75 years old2024
- Author(s)
  Kosuke Ueda, Naoki Ito, Satoshi Ohnishi, Hiroki Suekane, Hirofumi Kurose, Tasuku Hiroshige, Katsuaki Chikui, Keiichiro Uemura, Kiyoaki Nishihara, Makoto Nakiri, Shigetaka Suekane, Tsukasa Igawa
- Organizer
  第111回日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-23K08749
[Presentation] 進行性腎細胞癌における1次治療としてのImmuno-Oncology combination療法の意義2023
- Author(s)
  植田浩介、末金茂高、伊東直城、小笠原尚之、黒瀬浩文、広重佑、築井克聡、上村慶一郎、名切信、西原聖顕、松尾光哲、井川掌
- Organizer
  第52回　腎癌研究会
- Data Source
  KAKENHI-PROJECT-20K18128
[Presentation] Association between soluble immune checkpoint molecules expression and efficacy of immuno-oncology combination therapy in advanced renal cell carcinoma2023
- Author(s)
  Kosuke Ueda, Keiichiro Uemura, Shigetaka Suekane, Naoki Ito, Naoyuki Ogasawara, Hirofumi Kurose, Tasuku Hiroshige, Katsuaki Chikui, Kiyoaki Nishihara, Makoto Nakiri, Mitsunori Matsuo, Tsukasa Igawa
- Organizer
  第110回日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-23K08749
[Presentation] Absolute lymphocyte countは進行性腎細胞癌に対するNIVO+IPI併用療法の予後予測因子となりうる2023
- Author(s)
  植田　浩介、末金　茂高、伊東　直城、小笠原　尚之、黒瀬　浩文、広重　佑、築井　克聡、上村　慶一郎、名切　信、西原　聖顕、松尾　光哲、井川　掌
- Organizer
  日本泌尿器腫瘍学会　第8回学術集会
- Data Source
  KAKENHI-PROJECT-20K18128
[Presentation] Association between soluble immune checkpoint molecules expression and efficacy of immuno-oncology combination therapy in advanced renal cell carcinoma2023
- Author(s)
  Kosuke Ueda, Keiichiro Uemura , Naoki Ito, Yuya Sakai, Satoshi Ohnishi, Hiroki Suekane, Hirofumi Kurose, Tasuku Hiroshige, Kota Watanabe, Katsuaki Chikui, Kiyoaki Nishihara, Makoto Nakiri, Shigetaka Suekane, Tsukasa Igawa
- Organizer
  日本泌尿器腫瘍学会　第9回学術集会
- Data Source
  KAKENHI-PROJECT-23K08749
[Presentation] Association between soluble immune checkpoint molecules expression and efficacy of IO combination therapy in advanced renal cell carcinoma2023
- Author(s)
  Ueda Kosuke, Uemura Keiichiro, Suekane Shigetaka, Ito Naoki, Ogasawara Naoyuki, Kurose Hirofumi, Hiroshge Tasuku, Chikui Katsuaki, Nishihara Kiyoaki, Nakiri Makoto, Matsuo Mitsunori, Igawa Tsukasa
- Organizer
  第110回　日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-20K18128
[Presentation] 進行性腎細胞癌におけるNivolumab単独療法の効果に対する抗生剤の影響2021
- Author(s)
  植田　浩介、末金　茂高、小笠原　尚之、黒瀬　浩文、熊谷　壽二、築井　克聡、名切　信、西原　聖顕、松尾　光哲、井川　掌
- Organizer
  第42回癌免疫外科研究会
- Data Source
  KAKENHI-PROJECT-20K18128
[Presentation] 転移性腎細胞癌における免疫チェックポイント阻害剤の治療効果に対する抗生剤の影響2020
- Author(s)
  植田　浩介、小笠原　尚之、松永　祥弘、星野　龍志、黒瀬　浩文、築井　克聡、上村　慶一郎、名切　信、西原　聖顕、松尾　光哲、末金　茂高、井川　掌
- Organizer
  第58回日本癌治療学会学術集会
- Data Source
  KAKENHI-PROJECT-20K18128
[Presentation] 尿路上皮がん患者に対する個別化がんぺプチドワクチン療法のバイオマーカー2020
- Author(s)
  末金茂高、西原聖顕、植田浩介、由谷茂、七條茂樹、野口正典、伊東恭悟、井川掌
- Organizer
  第108回日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-18K09182
[Presentation] IO combo時代の転移性腎細胞癌における二次治療以降の薬物選択～TKIの位置づけ～2020
- Author(s)
  植田　浩介
- Organizer
  第72回西日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-20K18128
[Presentation] Feasibility of Personalized Peptide Vaccination for Urothelial Cancer Patients Without Distant Metastasis as a Preventive Cancer Vaccine2019
- Author(s)
  Suekane S,Ueda K,Nishihara K,Noguchi M,Yutani S,Shichijo S,Itoh K,Igawa T
- Organizer
  SIU　2019国際泌尿器科学会議
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K09182
[Presentation] 尿路上皮がん再発予防がんペプチドワクチンの免疫誘導能2019
- Author(s)
  末金　茂高、野口　正典、西原　聖顕、植田　浩介、由谷　茂、伊東　恭悟、井川　掌
- Organizer
  第40回癌免疫外科研究会
- Invited
- Data Source
  KAKENHI-PROJECT-18K09182
[Presentation] 尿路上皮がん患者に対する個別化がんペプチドワクチンの再発予防効果2019
- Author(s)
  末金　茂高、植田　浩介、西原　聖顕、野口　正典、伊東　恭悟、井川　掌
- Organizer
  第107回日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-18K09182

1. Suekane Shigetaka (40235833)

# of Collaborated Projects: 1 results

# of Collaborated Products: 10 results
2. 伊東恭悟 (50125499)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
3. 井川掌 (40295069)

# of Collaborated Projects: 1 results

# of Collaborated Products: 9 results
4. 西原聖顕 (90389297)

# of Collaborated Projects: 1 results

# of Collaborated Products: 9 results
5. 轟圭太 (60624434)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 秋葉純 (00341305)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 河原明彦 (00469347)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 安陪由思 (50748712)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 中山正道 (80795229)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 米倉慧 (20912736)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 太田啓介

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Ueda Kousuke 植田 浩介

Ueda Kosuke 植田 浩介

Research Projects

Research Products

Co-Researchers

口腔癌の癌幹細胞と周囲微小環境とのクロストーク機構解析による新規治療戦略の確立

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Association between efficacy of Immuno-Oncology combination therapy for renal cell carcinoma and gut microbiota including fungi and virusesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Association between anti-tumor effect of Kampo combined with anti-PD-1 antibody and interstinal microbiotaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Next generation personalized peptide vaccination for advanced urothelial carcinoma patients

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Three‐dimensional ultrastructural and anatomical analysis of prostatic neuroendocrine cells in mice2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Soluble Immune Checkpoint Molecules as Predictors of Efficacy in Immuno-Oncology Combination Therapy in Advanced Renal Cell Carcinoma2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prognostic Value of Absolute Lymphocyte Count in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab Plus Ipilimumab2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Impact of Gleason score of the tumor at the positive surgical margin as a prognostic factor2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Immune-related adverse events are clinical biomarkers to predict favorable outcomes in advanced renal cell carcinoma treated with nivolumab plus ipilimumab2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Improved Survival of Real-world Japanese Patients With Advanced Renal Cell Carcinoma Treated With Immuno-oncology Combination Therapy2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] FXYD3 Expression Predicts Poor Prognosis in Renal Cell Carcinoma with Immunosuppressive Tumor Microenvironment2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Survival outcomes of non?definitive therapy for muscle?invasive bladder cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Absolute lymphocyte count is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with nivolumab2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinoma2020

Ueda Kousuke 植田浩介

Ueda Kosuke 植田浩介